Fave Five: Triple Play (8/11/2017)

Fave Five (8/11/2017)

Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according to Analyst Consensus Estimates, or ACE) combined with strong long-term return forecasts and good/excellent quality rankings. The average 1-year ACE total return forecast is 8.7%.

This week we return to the triple play screening method for our five favorites. The triple play possibility occurs when you find a stock that is very depressed in price and also appears to be on the verge of substantially boosting its profit margins. The triple play effect is possible in that:

(1) The depressed price of the stock can return to normal levels;

(2) increased profit margins can produce increased EPS and a higher price;

(3) may also cause higher P/E ratios, or P/E expansion.

The Fave Five This Week

  • CVS Health (CVS)
  • Gentex (GNTX)
  • Korn Ferry (KFY)
  • Schwab (SCHW)
  • Starbucks (SBUX)

The Long and Short of This Week’s Fave Five

The Long & Short. (August 11, 2017) Projected Annual Return (PAR): Long term return forecast based on fundamental analysis and five year time horizon. Quality Ranking: Percentile ranking of composite that includes financial strength, earnings stability and relative growth & profitability. VL Low Total Return (VLLTR): Low total return forecast based on 3-5 year price targets via Value Line Investment Survey. Morningstar P/FV: Ratio of current price to fundamentally-based fair value via www.morningstar.com S&P P/FV: Current price-to-fair value ratio via Standard & Poor’s. 1-Year ACE Outlook: Total return forecast based on analyst consensus estimates for 1-year target price combined with current yield. The data is ranked (descending order) based on this criterion. 1-Year S&P Outlook: 1-year total return forecast based on S&P 1-year price target.

Fave Five Legacy (Tracking Portfolio)

The rate of return for the tracking portfolio is 14.5% since inception.

The relative/excess return for the Fave Five tracking portfolio is +1.7% since inception.

Tracking Dashboard: https://www.manifestinvesting.com/dashboards/public/fave-five

Fave Five (6/30/2017) Triple Play

Fave Five (6/30/2017)

Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according to Analyst Consensus Estimates, or ACE) combined with strong long-term return forecasts and good/excellent quality rankings. The average 1-year ACE total return forecast is 9.7%.

This week we return to the triple play screening method for our five favorites. The triple play possibility occurs when you find a stock that is very depressed in price and also appears to be on the verge of substantially boosting its profit margins. The triple play effect is possible in that:

(1) The depressed price of the stock can return to normal levels;

(2) increased profit margins can produce increased EPS and a higher price;

(3) may also cause higher P/E ratios, or P/E expansion.

The Fave Five This Week

  • CVS Health (CVS)
  • Gentex (GNTX)
  • IMAX (IMAX)
  • Infosys Tech (INFY)
  • Monro Muffler (MNRO)

The Long and Short of This Week’s Fave Five

The Long & Short. (June 30, 2017) Projected Annual Return (PAR): Long term return forecast based on fundamental analysis and five year time horizon. Quality Ranking: Percentile ranking of composite that includes financial strength, earnings stability and relative growth & profitability. VL Low Total Return (VLLTR): Low total return forecast based on 3-5 year price targets via Value Line Investment Survey. Morningstar P/FV: Ratio of current price to fundamentally-based fair value via www.morningstar.com S&P P/FV: Current price-to-fair value ratio via Standard & Poor’s. 1-Year ACE Outlook: Total return forecast based on analyst consensus estimates for 1-year target price combined with current yield. The data is ranked (descending order) based on this criterion. 1-Year S&P Outlook: 1-year total return forecast based on S&P 1-year price target. 1-Yr GS: 1-year total return forecast based on most recent price target issued by Goldman Sachs.

Fave Five Legacy (Tracking Portfolio)

The rate of return for the tracking portfolio is 15.2% since inception.

The relative/excess return for the Fave Five tracking portfolio is +0.2% since inception. 45.7% of selections have outperformed the Wilshire 5000 since original selection.

Tracking Dashboard: https://www.manifestinvesting.com/dashboards/public/fave-five

Round Table (May 2017)

These excerpts are from our monthly webcast series (The Round Table) that usually airs on the last Tuesday at 8:30 PM ET.  The sessions are FREE and include the selection of 3-5 stocks to study with a demonstration of the analysis used to determine the quality and return forecast.  This demonstration has beaten the market over the last seven years, featuring a collective rate of return of 13.2%.  A tracking portfolio is maintained at:
If you would like to be added to the reminder list for future sessions, send a request to be added to the list maintained at nkavula1@comcast.net

The Core/Non-Core discussion was a thought starter for sure. Clarifying my thought, adding ‘Successfully’ to ‘Survived At Least One Recession’ means to me that the company was ‘at least’ earnings profitable during a recession period. An example would be UTHR owned by the investment club I belong to. — Marty Eckerle, Cincinnati

[Here is one of the slides used in the discussion …]

Core mettle

 

Selling Decisions Based on Relative Return

Nothing about the traditional selling decision, or Challenge, changes. We still sell with the overall portfolio characteristics in mind. It’s a standard procedure to challenge the holdings with the lowest return forecast. This was referred to by George Nicholson as “Rule One” for portfolio management. For this month’s meeting, Coach (COH) was challenged, updated, analyzed and sold to provide some boost to overall portfolio PAR.

Following that, any company selected within the trailing 12 months that lags (falls behind) the Wilshire 5000 and exhibits a relative return of -20% is subjected to some “head scratching.” The following flow/decision chart is an attempt to capture this process.

Rt flow chart 20170530

Selling Decisions (May 2017)

How To Use This Chart. This chart summarizes the decisions made by checking various attributes of stocks that have triggered the -20% relative return threshold over the last year.

The first chart is a dashboard sorted by PAR (Ascending). The stock at the top of the sort, Coach (COH) is therefore — on the HOT SEAT. After further discussion and the update included in this thread (see below), Coach did not survive and was SOLD.

When a stock reaches a relative return of -20% (versus the Wilshire 5000, VTSMX) it qualifies for this raking over the coals. The relative performance is displayed in the Relative Return column. If LKQ (LKQ) can remain under -20%, it will be removed from this listing at future Round Tables.

Core? is a decision as to whether a stock should be subjected to tighter constraints or given “blue chip” treatment with a “longer leash.” Most participants tend to regard Retail/Apparel companies as Non-Core and we’ve found over the years that steady forecasts and steady results are generally the hallmark of companies that we consider to be core.

If a company is deemed to be core, a quick check of the return forecast (PAR) and Quality is in order to detect degradation or erosion of expectations. In this case NVO is definitely “on the fence” and we’re monitoring for signs of further weakness. It was noted that the stock price performance has been stronger over the last few weeks.

The last “life line” (vs. Industry) is a quick check to see if a company is actually faring relatively well versus its industry or peers while lagging the market. This essentially “saved” LKQ last month as we noted that the Auto & Commercial Vehicle Parts Index (BigCharts: WSJUSIXOTA) has lagged the overall stock market.

Coach (COH) was sold from the Round Table tracking portfolio on 5/30/2017.

Coh analysis 20170530

The Audience Poll was a bit of a photo finish for May 2017. We ruled that the audience selected both Dollar General (DG) and LGI Homes (LGIH) and will invest $1000 in each. The live audience in Cincinnati on 5/19/2017 selected CVS Health (CVS).

Rt poll 20170530

Round Table (March 2017)

Round Table (March 2017)

The March Round Table included some reminders about the virtues of a 8-year bull market — and the significant potential of using the Triple Play screening criteria. Take a look back at our features from March-April 2009 and a number of case studies (and smiles for many of us) erupt.

Archive: https://www.manifestinvesting.com/events/211-round-table-march-2017 (Will be added ASAP)

Stocks Presented

  • CVS Health (CVS)
  • EPAM Systems (EPAM)
  • Microchip Technology (MCHP)

The audience selected CVS Health (CVS).

Rt poll 20170328

Fave Five: Triple Play (3/3/2017)

Fave Five (3/3/2017)

Our Fave Five essentially represents a listing of stocks with favorable short term total return forecasts (1 year, according to Analyst Consensus Estimates, or ACE) combined with strong long-term return forecasts and good/excellent quality rankings. The average 1-year ACE total return forecast is 6.9%.

This week we return to the triple play screening method for our five favorites. The triple play possibility occurs when you find a stock that is very depressed in price and also appears to be on the verge of substantially boosting its profit margins. The triple play effect is possible in that:

(1) The depressed price of the stock can return to normal levels;

(2) increased profit margins can produce increased EPS and a higher price;

(3) may also cause higher P/E ratios, or P/E expansion.

The Fave Five This Week

  • Abbvie (ABBV)
  • CVS Health (CVS)
  • Infosys Tech (INFY)
  • Polaris (PII)
  • Proto Labs (PRLB)

The Long and Short of This Week’s Fave Five

The Long & Short. (March 3, 2017) Projected Annual Return (PAR): Long term return forecast based on fundamental analysis and five year time horizon. Quality Ranking: Percentile ranking of composite that includes financial strength, earnings stability and relative growth & profitability. VL Low Total Return (VLLTR): Low total return forecast based on 3-5 year price targets via Value Line Investment Survey. Morningstar P/FV: Ratio of current price to fundamentally-based fair value via www.morningstar.com S&P P/FV: Current price-to-fair value ratio via Standard & Poor’s. 1-Year ACE Outlook: Total return forecast based on analyst consensus estimates for 1-year target price combined with current yield. The data is ranked (descending order) based on this criterion. 1-Year S&P Outlook: 1-year total return forecast based on S&P 1-year price target. 1-Yr GS: 1-year total return forecast based on most recent price target issued by Goldman Sachs.

Fave Five Legacy (Tracking Portfolio)

The relative/excess return for the Fave Five tracking portfolio is +0.3% since inception. 53.1% of selections have outperformed the Wilshire 5000 since original selection.

Tracking Dashboard: https://www.manifestinvesting.com/dashboards/public/fave-five

Fave Five (12/30/2016)

Fave Five (12/30/2016)

The primary screening criteria is the MANIFEST Rank, our combination of return forecast and quality. By screening for companies greater than 99.44 — we’re looking at the top half of the top percentage of companies qualifying.

This week’s stock study selections are top shelf candidates — right next to the holiday elf.

For context, the average 1-year ACE total return forecast is currently 8.3% for the approximately 2400 companies in our coverage.

The Fave Five This Week: Five Ideas to Float

  • Abbvie (ABBV)
  • Buffalo Wild Wings (BWLD)
  • Cognizant Technology (CTSH)
  • CVS Health (CVS)
  • Silicon Motion Tech (SIMO)

The Long and Short of This Week’s Fave Five (Ivory Soap Special Edition)

Fave Five: The Long & Short. (December 30, 2016) Projected Annual Return (PAR): Long term return forecast based on fundamental analysis and five year time horizon. Quality Ranking: Percentile ranking of composite that includes financial strength, earnings stability and relative growth & profitability. VL Low Total Return (VLLTR): Low total return forecast based on 3-5 year price targets via Value Line Investment Survey. Morningstar P/FV: Ratio of current price to fundamentally-based fair value via www.morningstar.com S&P P/FV: Current price-to-fair value ratio via Standard & Poor’s. 1-Year ACE Outlook: Total return forecast based on analyst consensus estimates for 1-year target price combined with current yield. The data is ranked (descending order) based on this criterion. 1-Year S&P Outlook: 1-year total return forecast based on S&P 1-year price target. 1-Yr GS: 1-year total return forecast based on most recent price target issued by Goldman Sachs.

Fave Five Legacy (Tracking Portfolio)

The relative/excess return for the Fave Five tracking portfolio is +3.1% since inception. 44.4% of selections have outperformed the Wilshire 5000 since original selection.

Tracking Dashboard: https://www.manifestinvesting.com/dashboards/public/fave-five

Round Table (November 2016)

November Round Table

Our Round Table, a monthly session featuring our favorite stock ideas right now in true round table fashion, was held November 29.

Stocks Discussed

  • CVS Health (CVS)
  • Infosys Tech (INFY)
  • Mercadolibre (MELI)

The stocks selected for this program over the last six years have collectively beaten the Wilshire 5000. The excess return (annualized) has been ranging from 2-3%. We seek actionable opportunities to study and pursue.

The agenda will also include a continuation of our selling decision concept based on relative return.

The round table knights include small company champion and Mid-Michigan Director Ken Kavula; Cy (MythBuster) Lynch; pharmaceutical scientist Hugh McManus; and Manifest Investing’s Mark Robertson who will analyze their favorite stocks. Guest damsels have included Anne Manning, Susan Maciolek and Kim Butcher. Guest knights who have jousted include Nicholas Stratigos, Herb Lemcool and Matt Spielman.

The audience selected CVS Health (CVS).

Positions closed/sold: Knight Transportation (KNX), Landauer (LDR), PRA Group (PRAA), US Physical Therapy (USPH)

The tracking portfolio has been updated at: https://www.manifestinvesting.com/dashboards/public/round-table

Rt poll 20161129